During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

A multidrug regimen containing brentuximab vedotin (BV, Adcetris) proved feasible for older patients with advanced classical ...

A system that alerts doctors when high-risk cancer patients are admitted helped reduce hospital readmissions and shorten ...

IQVIA reports record $4B+ revenue in Q2 2025, driven by TAS & AI initiatives. Explore robust growth, R&D momentum, and strategic partnerships.

Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says ...

Teos announced in May it was winding down operations, following disappointing Phase II study results for its anti-TIGIT antibody.

A functional precision medicine platform intends to streamline cancer treatment by matching patients against a battery of FDA ...

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

Disparities in cancer care can often lead to delays, disruptions, and barriers to timely treatment, leading to an unmet need ...